Severe periodic febrile myalgia in infancy due to carnitine palmitoyltransferase deficiency

R Schiffmann1, E Lahat, A Schechter

  • 1Pediatric Neurology Unit, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel.

Insights

Recurrent febrile myalgia in a child was linked to carnitine palmitoyltransferase deficiency (CPTD). This metabolic disorder highlights the need for testing even without myoglobinuria.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Metabolic Disorders

Background:

  • Recurrent febrile myalgia can present with diverse symptoms including fever, vomiting, and pharyngitis.
  • The absence of myoglobinuria or exercise-induced muscle pain can complicate diagnosis.
  • Identifying underlying metabolic causes is crucial for effective management.

Observation:

  • A 7 1/2-year-old girl experienced severe, recurrent myalgia since infancy, accompanied by periodic fever, vomiting, and pharyngitis.
  • Diagnostic workup revealed no myoglobinuria or exercise-induced muscle pain.
  • Carnitine palmitoyltransferase deficiency (CPTD) was identified in leukocytes, fibroblasts, and muscle tissue.

Findings:

  • Carnitine palmitoyltransferase deficiency (CPTD) was confirmed as the underlying cause of the patient's symptoms.
  • The study demonstrates that CPTD can manifest as recurrent febrile myalgia without the typical presentation of myoglobinuria.
  • Leukocyte, fibroblast, and muscle biopsies were instrumental in diagnosing this metabolic myopathy.

Implications:

  • This case underscores the importance of considering metabolic etiologies, such as CPTD, in pediatric patients with recurrent febrile myalgia.
  • Diagnostic approaches for myalgia should include metabolic investigations, particularly when classic indicators like myoglobinuria are absent.
  • Early identification of CPTD allows for timely intervention and management of this genetic metabolic disorder.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...